The study demonstrated feasibility and safety: even high-dose NK infusions did not induce significant adverse reactions or GVHD, and patients showed a trend toward reduced 2-year relapse rates compared with historical controls.
← all excerpts
Synergistic immune interactions between T cells and natural killer cells in allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: current status and future directions.
1
—
—